Previous 10 | Next 10 |
Buy Dexcom, Abiomed, and Eargo on the dip: William BlairDexCom (DXCM), Abiomed (ABMD), and Eargo (EAR) have underperformed in the year so far, but citing their quarterly reports, William Blair’s Margaret Kaczor thinks the group of med-tech stocks are attractive buys on the pullback.Des...
Gainers: Precipio (PRPO) +23%, PDS Biotechnology (PDSB) +20%, Sensei Biotherapeutics (SNSE) +18%, Iovance Biotherapeutics (IOVA) +17%, Tyme Technologies (TYME) +12%.Losers: Black Diamond Therapeutics (BDTX) -30%, Aerpio Pharmaceuticals (A...
Iovance Biotherapeutics (IOVA) announces additional clinical for lifileucel alone and in combination with pembrolizumab in patients with advanced melanoma.An Overall Response Rate ((ORR)) of 86% was seen for lifileucel in combination with oembrolizumab in immune checkpoint inhibitor ((ICI))-n...
SAN FRANCISCO, May 19, 2021 (GLOBE NEWSWIRE) -- Hagens Berman urges Iovance Biotherapeutics, Inc. (NASDAQ: IOVA) investors with significant losses to submit your losses now . The firm is investigating possible securities law violations and certain investors may have valuable claims....
86% Overall Response Rate (ORR) for Lifileucel in Combination with Pembrolizumab in Immune Checkpoint Inhibitor (ICI) Naïve Advanced Melanoma Patients in IOV-COM-202 Clinical Study At Median of 28-Month Study Follow up, Median Duration of Response (DOR) not reached in Cohor...
Iovance Biotherapeutics ([[IOVA]] -38.7%) has lost more than a third after dual setbacks suffered within just two days.The announcement of regulatory feedback on potency assays for melanoma treatment lifileucel was followed by the sudden departure of company CEO Maria Fardis.In announcin...
Gainers: MoSys (MOSY) +32%.Lianluo Smart (LLIT) +30%.Advaxis (ADXS) +27%.Reata Pharmaceuticals (RETA) +22%.LifeMD (LFMD) +18%.Taitron Components (TAIT) +17%.FreightCar America (RAIL) +14%.Transcat (TRNS) +14%.PureCycle Technologies (PCT) +14%.Aehr Test Systems (AEHR) +12%.Losers:...
Shares of Iovance Biotherapeutics (NASDAQ: IOVA) were crashing 31.1% lower as of 11:57 a.m. EDT on Wednesday. The steep decline came after the company announced a delay in the U.S. regulatory filing for approval of cell therapy lifileucel. Iovance previously submitted data to th...
Iovance (IOVA) CEO Maria Fardis will resign, according to a company SEC filing.The news comes a day after the company reported it will delay a BLA submission for its lead asset, the melanoma treatment lifileucel, to 1H 2022.Fardis joined the company in 2016.Frederick Vogt, Iovance's gene...
Gainers: Reata Pharmaceuticals (RETA) +20%, LifeMD (LFMD) +13%, Eloxx Pharmaceuticals (ELOX) +10%, Cerecor (CERC) +10%, Biofrontera (BFRA) +7%.Losers: Onconova Therapeutics (ONTX) -23%, Iovance Biotherapeutics (IOVA) -18%,&...
News, Short Squeeze, Breakout and More Instantly...
Iovance Biotherapeutics Inc. Company Name:
IOVA Stock Symbol:
NASDAQ Market:
Iovance Biotherapeutics Inc. Website:
2024-07-26 10:45:04 ET Pacific Biosciences of California Inc (PACB) PACB is trading UP for the last 5 days, and it at trading at $2.10 with volume of 3,952,245 and a one day change of $0.19 (9.97%). Pacific Biosciences of California Inc has a 52-week low of 1.16 and a 52-week high o...
2024-07-14 05:45:00 ET Biotech stocks like Iovance Biotherapeutics (NASDAQ: IOVA) often look appealing because they could experience enormous growth in relatively short periods of time. Plus, over the long term, successful biotech companies have the opportunity to blossom into large...